TRENTON, N.J. (AP) — U.S. regulators have approved a modernized version of a decades-old antibiotic used to treat a number of infections.
Paratek Pharmaceuticals' Nuzyra (noo-ZAHY'-ruh) was designed to overcome the problem of resistance to tetracycline, an antibiotic widely used until recent years.
The company said late Tuesday that the Food and Drug Administration approved Nuzyra for treating bacterial pneumonia and severe skin infections.
Paratek plans to launch the antibiotic early next year, initially for use in hospitals. It hasn't disclosed the price.
Boston-based Paratek estimates its drug could eventually treat nearly 900,000 hospitalized U.S. patients annually.
